适合患有胆酸腹的成年人进行饮食疗法 (8×5饮食):可行性随机对照试验的方案
Yvonne A McKenzie1,2, Lawrence Kelman3, Michelle O'Connor3
1Faculty of Biology, Medicine and Health, The University of Manchester, Manchester, UK yvonne.mckenzie@postgrad.manchester.ac.uk.
BMJ open
|March 27, 2025
概括
本研究评估了针对胆酸性腹 (BAD) 的新饮食干预措施的可行性. 通过数字资源和营养学家咨询提供的8x5饮食旨在改善BAD患者的生活质量.
科学领域:
- 胃肠病学 胃肠病学
- 饮食干预 饮食干预
- 临床试验可行性临床试验可行性
背景情况:
- 胆酸性腹 (BAD) 显著影响患者的生活质量,需要有效的治疗.
- 目前BAD的治疗选择需要进一步调查以获得最佳的患者结果.
- 这项研究解决了改善BAD管理的国家优先事项.
研究的目的:
- 为了评估一种新型饮食模式的随机对照试验 (RCT) 的可行性,The 8x5 Diet.
- 为在BAD患者的8x5饮食中设计一个更大的,最终的RCT提供信息.
- 评估8x5饮食在患有BAD的成年人中的可接受性和潜在疗效.
主要方法:
- 一个可行性RCT将注册76英国成年人与BAD使用数字招聘.
- 参与者将被随机分配 (1:1) 到8周的通常护理或8x5饮食与营养学家的支持.
- 可行性将通过招聘,保留和可接受性进行评估;次要结果包括生活质量和症状缓解.
主要成果:
- 将收集可行性数据,包括招聘率,参与者保留率和干预接受度.
- 对二次结果的探索性分析将提供对饮食影响的初步见解.
- 该研究旨在提供数据,以证明更大规模的RCT是合理的.
结论:
- 将确定在胆酸腹患者中进行8x5饮食的RCT的可行性.
- 这些发现将指导开发更大的临床试验,以确定饮食的有效性.
- 这项研究有助于推进BAD患者的治疗选择.
相关概念视频
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
290
Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
290
Chronic Pancreatitis II: Collaborative Care
54
The management of chronic pancreatitis is multifaceted, involving a comprehensive approach that includes thorough assessment, diagnostic testing, and a variety of management strategies.
Assessment:
Assessment:
54
Drugs for Treatment of Diarrhea-Predominant IBS
133
Diarrhea-predominant irritable bowel syndrome (IBS-D) is a subtype of IBS characterized primarily by frequent, loose, or watery stools, abdominal pain, and abdominal discomfort. Therapeutic approaches to managing IBS-D include dietary changes, stress management techniques, and pharmaceutical interventions.
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
133
Drugs for Treatment of Constipation-Predominant IBS
124
Pharmacological therapies for IBS-C are designed to alleviate abdominal discomfort and enhance bowel function. In patients with IBS-C, fiber supplements may help soften stools and decrease straining, but may also lead to increased gas production and bloating. Osmotic laxatives like milk of magnesia are frequently used to soften stools and increase stool frequency in IBS-C patients. In addition, two drugs approved for use in severe IBS-C adult cases are linaclotide (Linzess) and lubiprostone...
124
Drugs for Treatment of Ulcerative Colitis in IBD
115
Ulcerative colitis is a chronic inflammatory condition primarily affecting the colon and rectum. The primary drugs used in the treatment of ulcerative colitis are aminosalicylates. They exhibit anti-inflammatory and immunosuppressive properties. They modulate inflammatory mediators and inhibit the activity of nuclear factor κB (NF-κB). Aminosalicylates also reduce inflammation by inhibiting prostaglandin and leukotriene production and decreasing neutrophil chemotaxis and superoxide...
115
Chronic Bowel Disorders: Introduction
375
Chronic bowel diseases are a group of long-term conditions affecting the digestive tract, characterized by inflammation and damage to the gut lining. These conditions primarily include irritable bowel syndrome and inflammatory bowel disease.
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
375


